Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)

NCT00542087 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

516

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: MK0663, etoricoxib / Duration of Treatment: 6 Weeks
DRUG: Comparator: diclofenac sodium / Duration of Treatment: 6 Weeks

Sponsor

Organon and Co